sk&f 100330-a has been researched along with 2-hydroxysaclofen in 1 studies
| Studies (sk&f 100330-a) | Trials (sk&f 100330-a) | Recent Studies (post-2010) (sk&f 100330-a) | Studies (2-hydroxysaclofen) | Trials (2-hydroxysaclofen) | Recent Studies (post-2010) (2-hydroxysaclofen) |
|---|---|---|---|---|---|
| 20 | 0 | 0 | 157 | 0 | 24 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capek, R; Esplin, B | 1 |
1 other study(ies) available for sk&f 100330-a and 2-hydroxysaclofen
| Article | Year |
|---|---|
Frequency-dependent enhancement of hippocampal inhibition by GABA uptake blockers.
Topics: Animals; Anticonvulsants; Baclofen; Dose-Response Relationship, Drug; Electric Stimulation; Evoked Potentials; GABA Antagonists; Hippocampus; In Vitro Techniques; Male; Nicotinic Acids; Nipecotic Acids; Pyramidal Tracts; Rats; Rats, Sprague-Dawley; Time Factors | 1993 |